Equities

Honliv Healthcare Management Group Co Ltd

Honliv Healthcare Management Group Co Ltd

Actions
  • Price (HKD)2.05
  • Today's Change0.00 / 0.00%
  • Shares traded2.00k
  • 1 Year change+0.99%
  • Beta--
Data delayed at least 15 minutes, as of Jul 26 2024 02:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Honliv Healthcare Management Group Co Ltd is an investment holding company principally engaged in the ownership, operation and management of hospitals. The Company, together with its subsidiaries, mainly provides treatment and general healthcare services and pharmaceutical sales. The Company's outpatient pharmaceutical treatment fields include the outpatient department, paediatrics, emergency department, haematology, obstetrics and gynaecology, dermatology, neurology, nails and breasts and preventive healthcare. The Company also engages in the provision of treatments and general healthcare services, including the sales of medical consumables and the provision of hospital ancillary services, and the sales of pharmaceuticals to patients, including both inpatients and outpatients. The Company mainly conducts its businesses in the domestic market and overseas markets.

  • Revenue in HKD (TTM)821.05m
  • Net income in HKD41.36m
  • Incorporated2004
  • Employees1.97k
  • Location
    Honliv Healthcare Management Group Co LtdNo. 8Bo Ai Road (South), Changyuan CountyXINXIANG ChinaCHN
  • Websitehttp://www.honlivhp.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.